OBD — Oxford Biodynamics Share News
0.000.00%
Last trade - 00:00- £7.08m
- £10.80m
- £1.10m
Brief: Oxford Biodynamics HY Operating Loss £5.99 Mln
Oxford BioDynamics - Half-year Report
RCS - Oxford BioDynamics - OBD's PSE test to be used in NCI trial
RCS - Oxford BioDynamics - OBD develops multi-cancer diagnostic test for dogs
Oxford BioDynamics - Notice of Results
Oxford BioDynamics - OBD partners with Goodbody Clinic on PSE test
Brief: Oxford Biodynamics Partners With The London Clinic
RCS - Oxford BioDynamics - OBD and King's College London collaborate on RA
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
Oxford BioDynamics - Holding(s) in Company
RCS - Oxford BioDynamics - OBD opens UK clinical testing facility
Brief: Oxford Biodynamics Raises Gross Proceeds Of 9.9 Mln STG Via Placing